Applied Genetic Technologies agtc.com


Public list: Pharma Startups (4743) Eye Health (701) Rare Diseases (230)

Applied Genetic Technologies Corporation is focused on developing gene therapy products derived from adeno-associated virus (AAV) for the treatment of inherited and acquired diseases. AGTC's lead product candidate is a treatment for Alpha One Antitrypsin Deficiency (Alpha-1). AGTC's treatment for Alpha-1, a debilitating respiratory disease caused by deficiencies in the tissue protective protein alpha one antitrypsin (AAT), has an outstanding safety profile in two Phase I human clinical trials co...Show all

Applied Genetic Technologies Corporation is focused on developing gene therapy products derived from adeno-associated virus (AAV) for the treatment of inherited and acquired diseases. AGTC's lead product candidate is a treatment for Alpha One Antitry...Show all

Company (IPO / Went public)

Phone: 386-462-2204

Fax: (386) 462-7396

14193 NW 119th Terrace
Suite 10
Alachua, 32615
Florida, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Applied Genetic Technologies $109.2M Mar 27, 2014
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Applied Genetic Technologies Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
InterWest PartnersVenture CapitalMenlo Park, California, United StatesSeries B, Debt - II, Series A - III, Debt, Series A - II, Series A, Seed VC
InterSouth PartnersVenture CapitalDurham, North Carolina, United StatesSeries B, Debt - II, Series A - III, Series A - II, Series A, Seed VC
Alta PartnersVenture CapitalSan Francisco, California, United StatesSeries B
MedImmune VenturesCorporate VentureGaithersburg, Maryland, United StatesSeries B, Debt - II, Series A - III, Series A, Seed VC
Foundation Fighting BlindnessNon-Profit FoundationColumbia, Maryland, United StatesGrant - III
See all 11 investors

Competitors

Company Status Description Investors
See all 15 competitors